A new two-dimensional aluminophosphate layer [Al 2 P 3 O 10 (OH) 2 ][C 6 NH 8 ] (compound 1 ) has been prepared from an alcoholic system using 4-methylpyridine (C 6 NH 7 ) as a template. The as-synthesized product is characterized by powder X-ray diffraction, dynamic thermogravimetric, and 31 P-, 27 Al-, and 13 C magic-angle spinning (MAS) NMR analyses. The structure has been solved by single-crystal X-ray diffraction analysis. Compound 1 crystallized in the monoclinic space group P 2 1 /c (no. 14), with a = 8.686 (3) Å, b = 21.240 (3) Å, c = 8.799 (2) Å, β = 113.23 (3)°, and Z = 4. The inorganic layers are constructed from alternating aluminum units (AlO 4 and AlO 5 ) and phosphorus units [PO 4, PO 3 (OH), PO 2 ( O)(OH)] and are featured by rows of edge-sharing bridged six-membered rings (6MRs) and zigzag four rings (4MRs). The layers are held with each other through strong H-bondings between the terminal oxygens attached to the 2-connected phosphate groups in adjacent layers. The organic ammonium cations (C 6 NH 8 + ) are located in the large cavities between the interlayer regions. The structural features and relationships in the anionic aluminophosphates with Al 2 P 3 O 12 3 - stoichiometry, including compound 1 and previously reported compounds, are discussed. Furthermore, new two-dimensional (2-D) networks have been proposed on the basis of the discovered building rules for aluminophosphates with Al 2 P 3 O 12 3 - stoichiometry.
No takes yet. Share an insight, caveat, or question.
Yu et al. (1998) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: